Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

Oncotarget · 2017 · PMC5355138 · PMID 28099151

Europe PMC DOI

hedged sentences

0.0670

closest p · 1.3× alpha

0.0720

boldest claim

The sentences

showed a trendP = 0.067so close (0.05 < p ≤ 0.1)

However, in a multivariate analysis of the 107 DLBCL patients with the non-GCB subtype, serum survivin positivity showed a trend toward an association with worse OS (HR 2.3; 95% CI, 0.9–5.6; P = 0.067).

also in 53,322 other papers

borderline significanceP = 0.072so close (0.05 < p ≤ 0.1)

The percentage of serum survivin-positive patients was higher in patents with relapsed or refractory disease than in those without it showing borderline significance (18.8% versus 9.2%, P = 0.072).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.